HSA Approval

APO-PIROXICAM CAPSULE 20 mg

Approval Number

SIN05893P

Drug Name

Product Name

APO-PIROXICAM CAPSULE 20 mg

Approval Date

May 22, 1991

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

Registrant

PHARMAFORTE SINGAPORE PTE LTD

Licence Holder

PHARMAFORTE SINGAPORE PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

M01AC01

ATC Item Name

piroxicam

Manufacturer Information

Pharmaceutical Manufacturer

PHARMAFORTE SINGAPORE PTE LTD

Manufacturers

APOTEX INC

Active Ingredients

Ingredient Name

PIROXICAM

Strength

20 mg

Drug MonographPiroxicam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APO-PIROXICAM CAPSULE 20 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

APO-PIROXICAM CAPSULE 20 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal